Good Life Advisors, LLC historic quarter change: Foreign Stocks, Added
In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 6 quarters from 2023-12-31 to 2025-06-30, Good Life Advisors, LLC opened 15 positions, added to 28, reduced 24 and sold out of 13.
- Q2 2025: Stock ARM; Country of operation —; Class SPONSORED ADS; Shares before 4,334.
- Q2 2025: Stock BTI; Country of operation —; Class SPONSORED ADR; Shares before 5,287.
- Q2 2025: Stock GPCR; Country of operation United States; Class SPONSORED ADS; Shares before 13,000.
- Q2 2025: Stock BP; Country of operation —; Class SPONSORED ADR; Shares before 15,667.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1696260), 6 quarters: Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-08); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-04-17); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-03); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-10-16); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-07-18); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-03). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2016-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q2 2025 | ARM
ARM HOLDINGS PLC | | SPONSORED ADS | 4,334 | 4,382 | +48 | $462,833 | $708,747 | +$245,914 | 2025-08-08 |
|---|
| Q2 2025 | BTI
BRITISH AMERN TOB PLC | | SPONSORED ADR | 5,287 | 6,898 | +1,611 | $218,744 | $326,485 | +$107,741 | 2025-08-08 |
|---|
| Q2 2025 | GPCR
STRUCTURE THERAPEUTICS INC | United States | SPONSORED ADS | 13,000 | 15,000 | +2,000 | $225,030 | $311,100 | +$86,070 | 2025-08-08 |
|---|
| Q2 2025 | BP
BP PLC | | SPONSORED ADR | 15,667 | 16,709 | +1,042 | $529,390 | $500,108 | -$29,282 | 2025-08-08 |
|---|
| Q1 2025 | SHEL
SHELL PLC | | SPON ADS | 3,735 | 4,500 | +765 | $234,016 | $329,791 | +$95,775 | 2025-04-17 |
|---|
| Q1 2025 | BP
BP PLC | | SPONSORED ADR | 14,703 | 15,667 | +964 | $434,632 | $529,390 | +$94,758 | 2025-04-17 |
|---|
| Q1 2025 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 4,208 | 5,218 | +1,010 | $238,593 | $310,725 | +$72,132 | 2025-04-17 |
|---|
| Q1 2025 | NVS
NOVARTIS AG | | SPONSORED ADR | 2,340 | 2,380 | +40 | $227,669 | $265,275 | +$37,606 | 2025-04-17 |
|---|
| Q1 2025 | ARM
ARM HOLDINGS PLC | | SPONSORED ADS | 3,526 | 4,334 | +808 | $434,968 | $462,833 | +$27,865 | 2025-04-17 |
|---|
| Q3 2024 | BP
BP PLC | | SPONSORED ADR | 14,572 | 29,182 | +14,610 | $526,040 | $916,004 | +$389,964 | 2024-10-16 |
|---|
| Q3 2024 | NVO
NOVO-NORDISK A S | | ADR | 26,362 | 28,655 | +2,293 | $3,762,904 | $3,411,673 | -$351,231 | 2024-10-16 |
|---|
| Q3 2024 | BWAY
BRAINSWAY LTD | | SPONSORED ADS | 33,720 | 55,800 | +22,080 | $204,680 | $515,592 | +$310,912 | 2024-10-16 |
|---|
| Q3 2024 | GSK
GSK PLC | | SPONSORED ADR | 7,622 | 14,486 | +6,864 | $293,441 | $592,178 | +$298,737 | 2024-10-16 |
|---|
| Q3 2024 | TSM
TAIWAN SEMICONDUCTOR MFG LTD | | SPONSORED ADS | 3,020 | 3,786 | +766 | $524,839 | $657,547 | +$132,708 | 2024-10-16 |
|---|
| Q3 2024 | ARM
ARM HOLDINGS PLC | | SPONSORED ADS | 3,051 | 4,090 | +1,039 | $499,201 | $584,908 | +$85,707 | 2024-10-16 |
|---|
| Q3 2024 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 4,340 | 4,536 | +196 | $238,683 | $294,666 | +$55,983 | 2024-10-16 |
|---|
| Q3 2024 | SHEL
SHELL PLC | | SPON ADS | 3,905 | 4,368 | +463 | $281,864 | $288,097 | +$6,233 | 2024-10-16 |
|---|
| Q2 2024 | NVO
NOVO-NORDISK A S | | ADR | 23,967 | 26,362 | +2,395 | $3,077,313 | $3,762,904 | +$685,591 | 2024-07-18 |
|---|
| Q2 2024 | TSM
TAIWAN SEMICONDUCTOR MFG LTD | | SPONSORED ADS | 2,551 | 3,020 | +469 | $347,117 | $524,839 | +$177,722 | 2024-07-18 |
|---|
| Q2 2024 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 4,050 | 4,340 | +290 | $203,292 | $238,683 | +$35,391 | 2024-07-18 |
|---|
| Q2 2024 | SHEL
SHELL PLC | | SPON ADS | 3,767 | 3,905 | +138 | $252,548 | $281,864 | +$29,316 | 2024-07-18 |
|---|
| Q2 2024 | NVS
NOVARTIS AG | | SPONSORED ADR | 2,368 | 2,390 | +22 | $229,017 | $254,451 | +$25,434 | 2024-07-18 |
|---|
| Q2 2024 | GSK
GSK PLC | | SPONSORED ADR | 6,941 | 7,622 | +681 | $297,568 | $293,441 | -$4,127 | 2024-07-18 |
|---|
| Q2 2024 | BP
BP PLC | | SPONSORED ADR | 14,048 | 14,572 | +524 | $529,317 | $526,040 | -$3,277 | 2024-07-18 |
|---|
| Q2 2024 | SNY
SANOFI | | SPONSORED ADR | 4,410 | 4,470 | +60 | $214,328 | $216,908 | +$2,580 | 2024-07-18 |
|---|
| Q1 2024 | NVO
NOVO-NORDISK A S | | ADR | 22,475 | 23,967 | +1,492 | $2,325,118 | $3,077,313 | +$752,195 | 2024-05-03 |
|---|
| Q1 2024 | TSM
TAIWAN SEMICONDUCTOR MFG LTD | | SPONSORED ADS | 2,174 | 2,551 | +377 | $226,106 | $347,117 | +$121,011 | 2024-05-03 |
|---|
| Q1 2024 | NVS
NOVARTIS AG | | SPONSORED ADR | 2,348 | 2,368 | +20 | $237,137 | $229,017 | -$8,120 | 2024-05-03 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |